Taken together, these observations indicated that FeTPPS attenuates caspase-11 activation in vivo, which is driven by hepatocyte-released HMGB1 in endotoxemia or bacterial sepsis. The gene discussed is HMGB1; the disease is serum lipopolysaccharide activity.